Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001471518-23-000004
Filing Date
2023-06-02
Accepted
2023-06-02 18:00:55
Documents
3
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685743243.html 4  
1 FORM 4 wk-form4_1685743243.xml 4 4196
2 EX-24 phanstielpoaform20220627.htm EX-24 4363
3 GRAPHIC phanstielpoaform20220627001.jpg GRAPHIC 260505
  Complete submission text file 0001471518-23-000004.txt   368794
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Phanstiel S. Louise (Reporting) CIK: 0001471518 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23990513